Conditions: Idiopathic Thrombocytopenic Purpura
Keywords: AMG 531 Idiopathic Thrombocytopenic Purpura ITP Thrombocytopenia Japan Placebo controlled Phase 3
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 34
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of AMG 531 compared with placebo in thrombocytopenic Japanese subjects with immune (idiopathic) thrombocytopenic purpura (ITP) .

Detailed description:

Arms:
arm 1: Double blinded placebo-controlled study arm 2: None

Interventions: intervention 1: Placebo intervention 2: AMG 531
Intervention descriptions: intervention 1: Subcutaneously administered, once a week, for 12 weeks intervention 2: Subcutaneously administered, once a week, for 12 weeks

Protocol document: